Momenta Pharmaceuticals shares were up almost 70 per cent in pre-market trading, almost equal to the premium offered by Johnson and Johnson. Photograph: Jeff Overs/BBC via Getty Images

Johnson and Johnson has agreed to buy biotech Momenta Pharmaceuticals for $6.5 billion (€5.5 billion) in an all-cash deal that will expand its portfol(...)

Profits fell by a third at Johnson & Johnson’s Janssen unit in Cork as sales fell and it made a €46.9 million provision for personal injury claims(...)

One of the first bonefish to be caught at Delphi Club, Bahamas since Hurricane Dorian

Sherkin Island Marine Station has announced the winners of its 22nd annual environmental awareness competition for Munster primary schools, which incl(...)

Johnson & Johnson has been fined by a US court for its marketing of Risperdal. Photograph: JB Reed/Bloomberg

A Philadelphia jury on Tuesday hit Johnson & Johnson with an $8 billion verdict over its marketing of the anti-psychotic drug Risperdal, siding wi(...)

 Bottles of several opioid based medication at a pharmacy in  Ohio. Photograph: REUTERS/Bryan Woolston/File Photo

Turn on a TV set or YouTube video in America today and it won’t take long before you’ll encounter a drug company’s ad telling you how their product ca(...)

  Deciphex chief executive Donal O’Shea and  chief operations officer Mairin Rafferty.  The idea for Deciphex was born over dinner in late 2016 when Mr O’Shea was at a pathology conference in London. Photograph: Nick Bradshaw

Using a combination of artificial intelligence (AI) and computer-aided diagnostics, DCU-based startup Deciphex has developed a solution to speed throu(...)

Ireland is also one of the largest exporters of medical products in Europe with annual sales of €12.6 billion to more than 100 companies worldwide
Broad-based strengths

Ireland’s life sciences sector is broadly based and has developed considerable strengths over the past five decades and more. Indeed, it is among the (...)

‘What we are doing in the universities is to support those people in developing solutions to challenges which are coming down the line,’ says Prof Kieran Hodnett

When most of us think about medicines, it is the finished products that come to mind: the shiny tablets or capsules that come in jars and packets. We(...)